RepliCel Life Sciences Inc (TSX:RP)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RP

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RP

  • Market CapCAD4.340m
  • SymbolTSX:RP
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA76027P4006

Company Profile

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from Licensing fees.RepliCel Life Sciences Inc is a regenerative medicine company which focuses on developing autologous cell therapies that treat functional cellular deficits.

Latest RP news

Currently there for this company. Visit our news hub for other news .